GHK-Cu, the copper complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK), is a naturally occurring copper-binding peptide that was first identified in human plasma by Loren Pickart in 1973. The compound was initially characterized in the context of liver cell research, where it was observed to influence cellular behavior in ways that distinguished it from other plasma fractions examined in the same experimental series. Subsequent research identified GHK as a component of several biological fluids and tissues, including urine, saliva, and wound fluid, with circulating plasma concentrations reported to decline with advancing age in published studies examining its distribution across age groups. The copper ion coordinated within the GHK-Cu complex has been proposed in the published literature as integral to the compound’s biological activity, with in vitro research characterizing the copper coordination chemistry and its relationship to the cellular responses observed in experimental settings. The compound has been examined across a broad range of preclinical research contexts spanning dermatological biology, wound biology, neurological research, and gene expression studies, making it one of the more extensively researched naturally derived copper peptide complexes in the published scientific literature. GHK-Cu is available for research purposes and is not intended for human or veterinary use.

Chemical and Structural Profile

GHK-Cu is a copper complex of the linear tripeptide glycyl-L-histidyl-L-lysine, with the molecular formula of the copper complex represented as C14H23CuN6O4 and a molecular weight of approximately 403.9 daltons for the copper-coordinated form. The tripeptide sequence Gly-His-Lys coordinates a single cupric ion (Cu2+) through a square planar coordination geometry involving the alpha-amino group of glycine, the imidazole nitrogen of histidine, and the deprotonated amide nitrogen of the glycine-histidine peptide bond, a coordination arrangement that has been characterized through published spectroscopic and crystallographic research on the GHK-copper coordination chemistry.

As a tripeptide, GHK represents one of the smallest peptide-based research compounds examined in the published biological literature, and its compact structure contributes to distinctive solubility and tissue distribution properties that have been noted in preclinical research examining the compound’s behavior in biological model systems. The histidine residue at the central position of the sequence is the primary determinant of the compound’s copper chelation properties, given the well-characterized copper-binding affinity of the imidazole side chain as established in inorganic coordination chemistry literature. The copper coordination is reversible under certain conditions, and the equilibrium between the copper-bound and copper-free forms of the peptide in aqueous solution is influenced by pH, competing ligands, and copper ion concentration, all of which are relevant considerations for researchers designing experimental protocols involving this compound.

Research-grade GHK-Cu is supplied as a lyophilized powder in its copper-complexed form, which provides greater stability during storage than aqueous formulations. The compound exhibits characteristic blue-violet coloration in solution due to the d-d electronic transitions of the coordinated cupric ion, a property that serves as a visual indicator of copper coordination integrity in reconstituted research preparations. High-performance liquid chromatography (HPLC) is the standard analytical method for purity assessment of the peptide component, with atomic absorption spectroscopy or inductively coupled plasma mass spectrometry used to verify the copper content and stoichiometry of the complex in research-grade preparations.

Mechanism of Action

The mechanistic research on GHK-Cu is notably diverse relative to many other research peptides, reflecting the compound’s observed activity across multiple cellular systems and biological pathways in published in vitro and animal model research. Unlike peptides that act through a single well-defined receptor, published research has characterized GHK-Cu as influencing cellular behavior through several proposed mechanisms, including modulation of gene expression, interaction with extracellular matrix components, and copper-mediated enzymatic activity, with the relative contributions of these mechanisms varying by cell type and experimental context in the published literature.

Published gene expression research using microarray and transcriptomic approaches has examined the effects of GHK-Cu treatment on gene expression profiles in human fibroblast cell cultures and other cell types, with findings reported by Pickart and colleagues and by subsequent independent research groups examining gene ontology categories associated with extracellular matrix synthesis, inflammatory pathway regulation, and cellular signaling. A widely cited gene expression analysis published by Pickart and Margolina reported that GHK-Cu influenced the expression of a substantial number of human genes in cell culture systems, with the affected genes distributed across functional categories including matrix metalloproteinase (MMP) regulation, collagen synthesis, and antioxidant pathway components. These in vitro gene expression findings have been proposed in the published literature as a mechanistic basis for understanding the diverse cellular responses to GHK-Cu treatment reported across different experimental model systems, though the precise molecular targets through which the compound initiates these gene expression changes have not been fully characterized.

The copper ion component of GHK-Cu has been examined in published research as a cofactor for copper-dependent enzymes including lysyl oxidase, an enzyme involved in collagen and elastin crosslinking that is relevant to extracellular matrix biology research. In vitro studies have examined the ability of GHK-Cu to serve as a copper delivery agent for copper-dependent enzymatic processes in cell culture systems, with published research reporting on the uptake of copper from the GHK-Cu complex by cultured cells and the subsequent utilization of the delivered copper in enzymatic reactions. Animal model research has examined GHK-Cu in wound biology contexts, with published studies reporting on extracellular matrix parameters, collagen deposition, and tissue architecture in treated versus control animals, though the mechanistic basis for the reported observations has been interpreted through multiple proposed pathways in the literature and remains an area of ongoing investigation.

Key Research Areas

Dermatological and Skin Biology Research

The most extensively published research area for GHK-Cu involves dermatological biology, with a substantial body of in vitro and animal model research examining the compound’s effects on skin cell types including fibroblasts, keratinocytes, and endothelial cells in culture systems. Pickart and colleagues have published extensively on GHK-Cu in dermatological research contexts, with in vitro studies examining fibroblast responses to GHK-Cu treatment including collagen synthesis markers, cell proliferation parameters, and extracellular matrix gene expression profiles. Animal model studies have examined GHK-Cu in rodent skin wound models, with published research reporting on histological parameters including collagen density, dermis thickness, and cellular composition in treated versus control tissue samples. The dermatological research literature for GHK-Cu is among the most substantive available for any copper peptide research compound and has informed the broader scientific understanding of copper peptide biology in skin tissue research contexts.

Wound Biology and Tissue Repair Research

A substantial portion of the published GHK-Cu literature has examined the compound in wound biology research contexts, with animal model studies investigating the compound’s effects on wound closure parameters, tissue architecture, and extracellular matrix composition in rodent wound models. Pickart published foundational research examining GHK-Cu in wound biology contexts beginning in the 1980s, with subsequent work from multiple independent research groups contributing to a body of literature that spans several decades of preclinical investigation. Published animal model studies have examined parameters including wound surface area reduction rates, collagen fibril organization, tensile strength of healed tissue, and angiogenic markers in wounds treated with GHK-Cu relative to vehicle-treated control wounds. The wound biology research area represents one of the most independently replicated portions of the GHK-Cu literature, though the mechanistic pathways underlying the reported observations have been attributed to multiple proposed mechanisms in the published literature, and the relative contributions of these mechanisms have not been uniformly established across independent research groups.

Gene Expression and Transcriptomic Research

Published research has examined the effects of GHK-Cu on gene expression profiles in cell culture systems using transcriptomic and gene ontology analysis approaches, representing a distinct and mechanistically informative research area within the broader GHK-Cu literature. Pickart and Margolina published analyses reporting that GHK-Cu influenced the expression of a large number of human genes in fibroblast cell cultures, with affected gene categories including extracellular matrix synthesis pathways, MMP regulation genes, antioxidant response elements, and inflammatory pathway components. Independent cell culture research has examined specific gene targets within these categories, with published studies reporting on changes in collagen type I and type III expression, MMP-1 and MMP-2 activity, and tissue inhibitor of metalloproteinase (TIMP) levels in GHK-Cu-treated cell preparations. The gene expression research area provides a mechanistic framework for interpreting the diverse cellular responses to GHK-Cu reported across different experimental systems, and published transcriptomic analyses have been referenced in subsequent research as a basis for generating specific mechanistic hypotheses testable in more targeted experimental designs.

Neurological and Neuroprotection Research

A smaller but published body of preclinical research has examined GHK-Cu in neurological research contexts, reflecting the established role of copper in neurological biology and the expression of copper-binding proteins and copper-dependent enzymes in neural tissue. Published cell culture research has examined GHK-Cu in nerve cell model systems, with studies reporting on neurite outgrowth parameters, cell survival markers, and oxidative stress indicators in treated neural cell preparations. Xu and colleagues published research examining GHK in the context of superoxide dismutase activity relevant to neurological oxidative stress research, providing a mechanistic rationale for investigating GHK-Cu in neural biology contexts. The neurological research area for GHK-Cu is less fully developed than the dermatological and wound biology literature, with the published evidence base consisting primarily of in vitro cell culture studies and a smaller number of animal model investigations that have examined the compound in the context of neurological injury or neurodegenerative disease research models.

Antioxidant and Oxidative Stress Research

Published in vitro research has examined GHK-Cu in the context of antioxidant biology and oxidative stress responses in cell culture systems, reflecting the well-established relationship between copper metabolism and oxidative stress biology as characterized in the broader metallobiochemistry literature. Cell culture studies have examined the effects of GHK-Cu on markers of oxidative stress in treated cells, including measurements of reactive oxygen species (ROS) levels, lipid peroxidation products, and antioxidant enzyme activity in treated versus control cell preparations. The copper ion component of GHK-Cu has been examined in published research for its potential role in superoxide dismutase-like catalytic activity, given the established role of copper in the active site of copper-zinc superoxide dismutase, though the specific antioxidant mechanisms attributable to the GHK-Cu complex versus free copper ion in experimental preparations require careful experimental design to distinguish. Published gene expression research has identified antioxidant response pathway genes among those influenced by GHK-Cu treatment in fibroblast cell cultures, providing a transcriptomic basis for further targeted investigation of the compound’s interactions with oxidative stress biology in preclinical research settings.

Research Considerations for Laboratory Use

Research-grade GHK-Cu is supplied as a lyophilized powder in its copper-complexed form and requires storage conditions appropriate for both the peptide component and the coordinated copper ion. Storage at -20 degrees Celsius or below is recommended for long-term preservation, with protection from light exposure during storage, as the cupric ion coordination can be sensitive to photoreductive conditions that may alter the copper oxidation state and thereby influence the compound’s behavior in experimental assay systems. The characteristic blue-violet coloration of GHK-Cu in aqueous solution provides a visual indicator of copper coordination integrity, and researchers should note any unexpected color changes in reconstituted preparations as a potential indicator of copper dissociation or oxidation state alteration during storage.

For laboratory reconstitution, sterile water or physiological buffer solutions are the standard reconstitution solvents used in research settings for GHK-Cu, with the choice of buffer composition and pH guided by the specific requirements of the experimental protocol and the sensitivity of the assay system to ionic strength and pH variation. The solubility of GHK-Cu in aqueous solutions is generally favorable under near-neutral pH conditions, though researchers should be aware that pH extremes can influence the copper coordination equilibrium and potentially alter the chemical form of the compound present in the experimental preparation. Researchers should avoid reconstitution in solutions containing competing metal chelators such as ethylenediaminetetraacetic acid (EDTA), which can strip the copper ion from the GHK-Cu complex and produce the copper-free tripeptide rather than the intact copper complex intended for use in the experimental system.

Purity specification is an important procurement consideration for GHK-Cu research, with two distinct analytical requirements applying to this compound relative to simpler peptide-only research compounds. First, the peptide purity of the GHK tripeptide component should be verified by HPLC to a specification of 99% or greater, consistent with research-grade peptide standards. Second, the copper content and stoichiometry of the complex should be verified by independent elemental analysis to confirm that the supplied material contains the copper-coordinated form of the compound rather than the copper-free tripeptide or an incompletely metalated preparation. A lot-specific certificate of analysis (COA) from an independent third-party testing laboratory should address both the peptide purity and the copper coordination verification for research procurement decisions involving this compound.

Published Literature and References

The published literature on GHK-Cu spans several decades and multiple independent research groups, making it one of the more extensively documented naturally derived copper peptide complexes in the preclinical research literature. The dermatological biology and wound biology research domains are the most thoroughly developed, with independent replication across multiple laboratories contributing to a substantive evidence base for the compound’s cellular effects in these research contexts. The gene expression and transcriptomic research area provides a mechanistic framework that has informed subsequent targeted investigations, while the neurological and antioxidant research areas represent smaller but published portions of the overall literature. The majority of published research has been conducted in cell culture systems and rodent animal models, with limited human research data available in the published record. This article is a research overview compiled from published scientific sources and does not constitute medical advice. Further preclinical and independent research is ongoing.

References:

Pickart L, 1973. Transport of copper by albumin-bound peptide. Nature. PMID: 4267210

Pickart L, Vasquez-Soltero JM, Margolina A, 2015. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International. PMID: 25883972

Pickart L, Margolina A, 2018. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. PMID: 30036934

Gorouhi F, Maibach HI, 2009. Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science. PMID: 19496987

Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP, 1988. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. PMID: 3350139

Buffoni F, Pino R, Dal Pozzo A, 1999. Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Archives Internationales de Pharmacodynamie et de Therapie. PMID: 10598060

Leyden JJ, Rawlings AV, 2002. Skin moisturization. Marcel Dekker. (Flag for verification – book chapter reference, not a PubMed-indexed journal article)

Hostynek JJ, Maibach HI, 2004. Copper and the skin. Dermatologic Clinics. PMID: 15542076

Pyo HJ, Kim IS, Kim BT, Lee SI, 2013. Effect of GHK-Cu on collagen and extracellular matrix gene expression in dermal fibroblasts. Journal of Peptide Science. (Flag for verification before publishing)

Abdulghani AA, Sherr S, Shirin S, Solodkina G, Tapia EM, Newman B, Philips N, 1998. Effects of topical creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skin. Disease Management and Clinical Outcomes. (Flag for verification before publishing)

---

This article is intended for informational and research reference purposes only. GHK-Cu is sold strictly for laboratory and research use. It is not intended for human or veterinary consumption, and this content does not constitute medical advice, treatment recommendations, or clinical guidance. All research applications referenced in this article are based on preclinical literature. Researchers should consult applicable regulations and institutional guidelines before use.